Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis
View ORCID ProfileMansour Tobaiqy, Saad Alhumaid, Abbas Al Mutair
doi: https://doi.org/10.1101/2020.06.16.20133298
Mansour Tobaiqy
1Department of Pharmacology, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
Saad Alhumaid
2Drug Information and Research Department, Administration of Pharmaceutical Care, Ministry of Health, Al-Ahsa, Saudi Arabia
Abbas Al Mutair
3Research Center, Dr Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia
Article usage
Posted June 19, 2020.
Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis
Mansour Tobaiqy, Saad Alhumaid, Abbas Al Mutair
medRxiv 2020.06.16.20133298; doi: https://doi.org/10.1101/2020.06.16.20133298
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)